
This two-year cohort study evaluated immunogenicity, safety, and reactogenicity in 1675 Brazilian healthcare workers who received CoronaVac as a primary protocol (PP) followed by heterologous boosters. All vaccines were safe, with no serious adverse events. Reactogenicity was highest for Ad26.COV2.S (62.86%) as a second booster, followed by Covishield (58.56%) and Comirnaty (42.62%); CoronaVac PP reactogenicity was 19.58%. Total anti-S IgG levels remained high throughout, increasing after the first booster. At 9 months post-PP, Comirnaty-boosted individuals showed superior responses versus CoronaVac alone, regardless of prior infection. No differences were observed between one or two boosters, age groups, or sex. Initially, previously infected participants had higher anti-S IgG (6–9 months), but this difference disappeared post-booster. Neutralizing antibodies against Omicron BA.1 were stronger in previously infected individuals at 6–12 months. The first booster increased neutralization in both groups; the second booster further enhanced responses in infection-naive individuals and maintained them in previously infected participants, with sustained activity up to 24 months. Participants with prior COVID-19 showed higher levels of immunological biomarkers early on, but this gap closed after the second booster, which elevated biomarkers in both groups. Cellular response, inferred from biomarker interactions, was generally higher in infection-naive individuals. These results underscore the importance of heterologous booster regimens in sustaining long-term humoral and cellular immunity against COVID-19.
Objectives This study investigated the prevalence of AmpC beta‐lactamase‐producing Escherichia coli and Klebsiella pneumoniae in clinical specimens collected in Lahore, Pakistan, and aimed to identify potential inhibitors targeting AmpC beta‐lactamases. Methods A total of 17,500 clinical specimens were collected from June 2018 to June 2021 and analyzed for E. coli and K. pneumoniae . These isolates underwent phenotypic identification using microscopy and the API 20E kit. AmpC beta‐lactamase production was initially screened using cefoxitin disk diffusion and inhibitor‐based methods, while the presence of plasmid‐borne AmpC genes (CIT, EBC, and DHA) was confirmed by PCR. Additionally, the study used computational drug discovery techniques to screen for oxadiazole, quinazolinone, and sulfonylurea derivatives as potential inhibitors of the AmpC protein. Results Our data showed high antibiotic resistance rates among E. coli and K. pneumoniae isolates: 74.5% were resistant to cefotaxime and ceftazidime, and 45% to cefoxitin. PCR testing revealed that the CIT gene was the most prevalent in both E. coli (65.4%) and K. pneumoniae (63%), while other genes (EBC and DHA) and combinations were also present ( p < 0.005). Using computational drug discovery, several compound libraries were screened against the AmpC protein. Tolbutamide showed the most promising results, with strong binding affinity and favorable drug‐like properties. Conclusion Plasmid‐mediated AmpC beta‐lactamase‐producing E. coli and K. pneumoniae were highly prevalent, with the CIT genotype predominating among clinical isolates. Computational screening identified Tolbutamide as a promising lead compound, warranting further experimental validation before therapeutic application.
Background: Healthcare workers are a first contact for patients with infectious diseases and may be at occupational risk during hemorrhagic fever outbreaks. The Marburg virus disease (MVD) outbreak in southern Ethiopia, ongoing during data collection in December 2025, highlighted the need to assess healthcare workers' knowledge, attitudes, and practices regarding MVD. Therefore, this study assessed knowledge, attitudes, and practices and examined factors associated with practice among healthcare work. Methods: A cross-sectional study of 238 healthcare workers at Dilla University Teaching Hospital was conducted from December 1 to December 22, 2025. Descriptive statistics, frequencies, and percentages summarized participant characteristics and KAP responses. Binary logistic regression examined factors associated with good practice. Variables with p value <= 0.25 in bivariable analysis were included in the multivariable model. Adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were calculated, and significance was set at p < 0.05. Results: About 51.7%, 57.1%, and 55.0% of participants had good knowledge, positive attitudes, and good practice toward MVD, respectively, based on study-specific cutoffs. Most identified direct contact with blood and body fluids as an MVD transmission route (92.0%). However, gaps were observed regarding environmental risk factors and MVD distribution and origin. Most recognized reporting suspected cases (91.2%), avoiding contact with infected individuals or their possessions (91.2%), and using personal protective equipment (87.8%). In multivariable analysis, modification of working habits from concern about acquiring MVD (AOR = 2.19, 95% CI: 1.21-3.99) and good MVD knowledge (AOR = 1.96, 95% CI: 1.13-3.39) were positively associated with good practice. Conclusion: Findings indicate gaps in MVD-related knowledge and infection prevention among healthcare workers at Dilla University Teaching Hospital. Targeted competency-based training, simulation, IPC resources, and facility-level preparedness systems are warranted to strengthen readiness for MVD and other viral hemorrhagic fever events.
Klebsiella pneumoniae (Kpn) is an opportunistic bacterium associated with various diseases, with significant morbidity and mortality due to treatment challenges posed by hypervirulent and multidrug-resistant (MDR) strains. This study investigates the prevalence of antimicrobial resistance, virulence factors, and clonal diversity of Kpn isolates. A total of 704 records were collected from the patient registries of two tertiary-care hospitals in Chattogram, Bangladesh. From these records, 123 biochemically confirmed clinical Klebsiella species were selected from admitted patients for molecular analysis. Antibiotic susceptibility, hypermucoid phenotype, and the presence of AMR genes (sul1, aadB) and the hypervirulence gene (rmpA) were determined. Whole-genome sequencing was also performed on one of the most drug-resistant isolates. Out of all isolates (n = 704), 72.59% were MDR, 18.89% DDR, and 7.95% DSDR. Among MDR, hospital-acquired infections (76%) were more prevalent than community-acquired infections (24%), with higher rates among geriatric (27%) and pediatric (25%) patients. The isolates showed high resistance to third-generation cephalosporins and the highest sensitivity to colistin. PCR analysis of the 81 phoE-positive isolates revealed that 85.18% carried the sul1 gene, while 6.17% harbored the aadB gene. Additionally, 12.34% were positive for the virulence gene rmpA, and 1.24% contained all three genes, sul1, aadB, and rmpA. Among the isolates, 65.43% were string test-positive. Notably, these string test-positive strains were resistant to most tested antibiotics compared to string test-negative strains. Whole-genome sequencing confirmed that KP-CU-1 as K. pneumoniae, with a 5.26 Mbp draft genome and an N50 of 164,530 bp, classified as sequence type 29 (ST29). This study indicates that MDR Kpn is highly prevalent, with a high proportion of hypervirulent strains. Establishing a nationwide AMR surveillance network will be essential to control the spread of MDR and hypervirulent Kpn in Bangladesh.
Background Antimicrobial resistance (AMR) is one of the most critical health concerns of the 21 st century, leading to increased mortality, prolonged hospital stays for patients, and higher healthcare costs. Despite urgency of AMR issue, comprehensive and comparative data on AMR in the Middle East region remain limited. This study aimed to systematically review and synthesize country‐level data on MRSA prevalence and resistance rates to seven commonly reported antibiotics, with the goal of identifying knowledge gaps and supporting evidence‐based antimicrobial stewardship policies and clinical decision‐making. Methods A comprehensive literature search was conducted across four electronic databases: PubMed, Web of Science (WOS), Scopus, and Google Scholar. The search included articles published from January 2015 to September 24, 2024. Search terms covered Staphylococcus aureus, AMR, and Middle Eastern countries. Ultimately, 217 studies with a combined sample size exceeding 32,090 were included in the analysis. Results In Iran, the highest and lowest pooled resistance rates were for penicillin G and vancomycin, respectively. For MRSA, the highest pooled resistance was observed in Iraq and the lowest in Turkey. Vancomycin pooled resistance was also the highest in Iraq. Gentamicin resistance was highest in Yemen and lowest in Cyprus and Kuwait. The highest pooled resistance rates for gentamicin, cotrimoxazole, and ciprofloxacin were all observed in Yemen. Conclusions Factors contributing to high AMR rates include ineffective antibiotic stewardship, self‐medication, prescription errors, inappropriate dosing, and excessive antibiotic use in agriculture. The findings highlight the urgent need for stricter antibiotic regulations, improved stewardship, and public awareness across the Middle East.